Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-15-016891
Filing Date
2015-09-04
Accepted
2015-09-04 16:42:02
Documents
4
Period of Report
2015-09-30
Effectiveness Date
2015-09-04

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A nby20150903_def14a.htm DEF 14A 168460
2 img2.jpg GRAPHIC 232977
3 img.jpg GRAPHIC 310479
4 nby20150903_def14aimg001.jpg GRAPHIC 6205
  Complete submission text file 0001437749-15-016891.txt   926847
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 151094886
SIC: 2834 Pharmaceutical Preparations